Cable Hill Partners’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-233
| Closed | -$2K | – | 767 |
|
|
2018
Q2 | $2K | Hold |
233
| – | – | ﹤0.01% | 813 |
|
|
2018
Q1 | $2K | Sell |
233
-352
| -60% | -$3.02K | ﹤0.01% | 806 |
|
|
2017
Q4 | $9K | Hold |
585
| – | – | ﹤0.01% | 584 |
|
|
2017
Q3 | $12K | Sell |
585
-1
| -0.2% | -$21 | 0.01% | 521 |
|
|
2017
Q2 | $9K | Sell |
586
-3
| -0.5% | -$46 | ﹤0.01% | 416 |
|
|
2017
Q1 | $5K | Buy |
589
+510
| +646% | +$4.33K | ﹤0.01% | 527 |
|
|
2016
Q4 | $1K | Sell |
79
-573
| -88% | -$7.25K | ﹤0.01% | 680 |
|
|
2016
Q3 | $6K | Sell |
652
-48
| -7% | -$442 | ﹤0.01% | 521 |
|
|
2016
Q2 | $6K | Hold |
700
| – | – | ﹤0.01% | 459 |
|
|
2016
Q1 | $7K | Buy |
700
+79
| +13% | +$790 | 0.01% | 409 |
|
|
2015
Q4 | $9K | Buy |
+621
| New | +$9K | 0.01% | 365 |
|